Search filters

List of works by Carmen Tur

A multi-shell multi-tissue diffusion study of brain connectivity in early multiple sclerosis

scientific article published on 10 May 2019

An observational study of the effectiveness and safety of natalizumab in the treatment of multiple sclerosis.

scientific article published in March 2011

Assessing treatment outcomes in multiple sclerosis trials and in the clinical setting

scientific article published on 12 January 2018

Association of Autonomic Dysfunction With Disease Progression and Survival in Parkinson Disease.

scientific article

Brain atrophy 15 years after CIS: Baseline and follow-up clinico-radiological correlations.

scientific article published in April 2017

Brain atrophy in natalizumab-treated patients: A 3-year follow-up

scientific article published on 12 November 2014

CSF oligoclonal bands are important in the diagnosis of multiple sclerosis, unreasonably downplayed by the McDonald criteria 2010: No.

scientific article published in May 2013

Change in the clinical activity of multiple sclerosis after treatment switch for suboptimal response

article

Clinical relevance of cortical network dynamics in early primary progressive MS

scientific article published on 25 February 2019

Comment on 'Fingolimod to treat severe MS after natalizumab-associated progressive multifocal leukoencephalopathy: a valid option?' Maillart et al

scientific article published on 27 January 2014

Comment on severe demyelination but no astrocytopathy in clinically definite neuromyelitis optica with anti-myelin-oligodendrocyte glycoprotein antibody

scientific article published on 06 February 2015

Commentary on Pique et al.'s paper entitled: Peripheral late reactivation of a previously typical monofocal Balo's concentric sclerosis lesion.

scientific article published on 26 May 2015

Complementary roles of grey matter MTR and T2 lesions in predicting progression in early PPMS

scientific article published on 25 October 2010

Contribution of the symptomatic lesion in establishing MS diagnosis and prognosis

scientific article

Deep grey matter volume loss drives disability worsening in multiple sclerosis.

scientific article published on 13 January 2018

Defining high, medium and low impact prognostic factors for developing multiple sclerosis

scientific article published on 21 April 2015

Disability progression markers over 6-12 years in interferon-β-treated multiple sclerosis patients.

scientific article

Disrupted principal network organisation in multiple sclerosis relates to disability

scientific article published on 27 February 2020

Do multimodal evoked potentials add information to MRI in clinically isolated syndromes?

scientific article published on 7 December 2009

Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis?

scientific article published on 19 September 2007

Early accurate diagnosis crucial in multiple sclerosis

scientific article published on September 2015

Early brain pseudoatrophy while on natalizumab therapy is due to white matter volume changes.

scientific article

Erratum: Author Correction: High-dimensional detection of imaging response to treatment in multiple sclerosis

scientific article published on 16 July 2019

Evaluating the response to glatiramer acetate in relapsing–remitting multiple sclerosis (RRMS) patients

article

Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis--establishing disease prognosis and monitoring patients

scientific article published on 15 September 2015

Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis—clinical implementation in the diagnostic process

scientific article (publication date: 7 July 2015)

Fatigue Management in Multiple Sclerosis

scientific article

Fully automated segmentation of the cervical cord from T1-weighted MRI using PropSeg: Application to multiple sclerosis

scientific article

Fármacos modificadores de la enfermedad en la esclerosis múltiple y embarazo

Grey matter atrophy is associated with disability increase in natalizumab-treated patients.

scientific article published on 28 June 2016

Grey matter damage and overall cognitive impairment in primary progressive multiple sclerosis.

scientific article published on 29 July 2011

HLA-DRB*1501 associations with magnetic resonance imaging measures of grey matter pathology in multiple sclerosis

scientific article published on 7 March 2016

HLA-DRB1*15 influences the development of brain tissue damage in early PPMS

scientific article

Has the time come to revisit our standard measures of disability progression in MS?

scientific article published on 26 October 2020

Head-to-head drug comparisons in multiple sclerosis: Urgent action needed

scientific article published on 07 October 2019

Hemichorea-hemiballism secondary to infarction in the primary motor area: an atypical form of presentation of Moya moya syndrome

scientific article published on 01 May 2011

High-dimensional detection of imaging response to treatment in multiple sclerosis

scientific article published on 10 June 2019

Ibudilast: a paradigm shift for progressive MS?

scientific article published on 02 December 2020

Inclusion of optic nerve involvement in dissemination in space criteria for multiple sclerosis

scientific article published on 17 August 2018

Interferon β-1b for the treatment of primary progressive multiple sclerosis: five-year clinical trial follow-up.

scientific article published in November 2011

Longitudinal evidence for anterograde trans-synaptic degeneration after optic neuritis.

scientific article published on 17 February 2016

Multiple sclerosis risk perception and acceptance for Brazilian patients

scientific article published in January 2018

NMO spectrum disorders: how wide is the spectrum?

scientific article published on 01 September 2014

Natalizumab discontinuation after PML risk stratification: outcome from a shared and informed decision

scientific article published on 01 March 2012

Natalizumab: risk stratification of individual patients with multiple sclerosis

scientific article

Neurite dispersion: a new marker of multiple sclerosis spinal cord pathology?

scientific article published on 15 August 2017

Neurofilament light chain level is a weak risk factor for the development of MS.

scientific article published on 12 August 2016

Oral laquinimod for multiple sclerosis: beyond the anti-inflammatory effect

scientific article published on 17 September 2013

Possible new modifications for the McDonald 2010 criteria for the diagnosis of primary progressive multiple sclerosis.

scientific article

Primary progressive multiple sclerosis diagnostic criteria: a reappraisal.

scientific article published on 7 December 2009

Progression of regional grey matter atrophy in multiple sclerosis.

scientific article published in June 2018

Progressive MS trials: Lessons learned

scientific article published in October 2017

Reduced gamma-aminobutyric acid concentration is associated with physical disability in progressive multiple sclerosis.

scientific article

Relationship between MRI lesion activity and response to IFN-β in relapsing–remitting multiple sclerosis patients

article

Response to the commentary of Yates RL and DeLuca GC on the study: HLA-DRB1*1501 associations with magnetic resonance imaging measures of grey matter pathology in multiple sclerosis.

scientific article published on 12 August 2016

Risk acceptance in multiple sclerosis patients on natalizumab treatment.

scientific article

Secondary progression is not the only explanation.

scientific article published in May 2014

Secondary progressive NMO, or concomitant NMO and a primary neurodegenerative disorder?

scientific article published on 10 September 2015

Should we systematically test patients with clinically isolated syndrome for auto-antibodies?

scientific article published on 16 March 2015

Significant clinical worsening after natalizumab withdrawal: Predictive factors

article

Single-subject structural cortical networks in clinically isolated syndrome

scientific article published on 24 July 2019

Spatial variability and changes of metabolite concentrations in the cortico-spinal tract in multiple sclerosis using coronal CSI

scientific article

Spinal cord atrophy as a primary outcome measure in phase II trials of progressive multiple sclerosis.

scientific article published in May 2017

Spinal cord lesions: A modest contributor to diagnosis in clinically isolated syndromes but a relevant prognostic factor

scientific article

Structural cortical network reorganization associated with early conversion to multiple sclerosis

scientific article published in Scientific Reports

Subcutaneous alemtuzumab for multiple sclerosis ⬇️

scientific article published on 01 July 2012

Understanding the role of gender and hormones in multiple sclerosis

Value of NMO-IgG determination at the time of presentation as CIS

scientific article published on 02 May 2012

Value of the central vein sign at 3T to differentiate MS from seropositive NMOSD

scientific article published on 07 March 2018

Very early scans for demonstrating dissemination in time in multiple sclerosis

scientific article published on 01 June 2008

[Acute disseminated encephalomyelitis: study of factors involved in a possible development towards multiple sclerosis]

scientific article published on 01 November 2008

Paulina is supported by:

About Paulina

Help